4.1 Review

Structural biology and chemistry of protein arginine methyltransferases

期刊

MEDCHEMCOMM
卷 5, 期 12, 页码 1779-1788

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/c4md00269e

关键词

-

资金

  1. AbbVie
  2. Bayer
  3. Boehringer Ingelheim
  4. Genome Canada through the Ontario Genomics Institute [OGI-055]
  5. GlaxoSmithKline
  6. Janssen
  7. Lilly Canada
  8. Novartis Research Foundation
  9. Ontario Ministry of Economic Development and Innovation
  10. Pfizer
  11. Takeda
  12. Wellcome Trust [092809/Z/10/Z]

向作者/读者索取更多资源

Protein arginine methyltransferases (PRMTs), an emerging target class in drug discovery, can methylate histones and other substrates, and can be divided into three subgroups, based on the methylation pattern of the reaction product (monomethylation, symmetrical or asymmetrical dimethylation). Here, we review the growing body of structural information characterizing this protein family, including structures in complex with substrate-competitive and allosteric inhibitors. We outline structural differences between type I, II and III enzymes and propose a model underlying class-specificity. We analyze the structural plasticity and diversity of the substrate, cofactor and allosteric binding sites, and propose that the conformational dynamics of PRMTs can be exploited towards the discovery of allosteric inhibitors that would antagonize conformationally active states.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

The natural flavone fukugetin as a mixed-type inhibitor for human tissue kallikreins

Jorge A. N. Santos, Marcia Y. Kondo, Renato F. Freitas, Marcelo H. dos Santos, Teodorico C. Ramalho, Diego M. Assis, Luiz Juliano, Maria A. Juliano, Luciano Puzer

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

Article Chemistry, Medicinal

Discovery of a Potent and Selective Coactivator Associated Arginine Methyltransferase 1 (CARM1) Inhibitor by Virtual Screening

Renato Ferreira de Freitas, Mohammad S. Eram, David Smil, Magdalena M. Szewczyk, Steven Kennedy, Peter J. Brown, Vijayaratnam Santhakumar, Dalia Barsyte-Lovejoy, Cheryl H. Arrowsmith, Masoud Vedadi, Matthieu Schapira

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6

Yudao Shen, Magdalena M. Szewczyk, Mohammad S. Eram, David Smil, H. Umit Kaniskan, Renato Ferreira de Freitas, Guillermo Senisterra, Fengling Li, Matthieu Schapira, Peter J. Brown, Cheryl H. Arrowsmith, Dalia Barsyte-Lovejoy, Jing Liu, Masoud Vedadi, Jian Jin

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor

Renato Ferreira de Freitas, Mohammad S. Eram, Magdalena M. Szewczyk, Holger Steuber, David Smil, Hong Wu, Fengling Li, Guillermo Senisterra, Aiping Dong, Peter J. Brown, Marion Hitchcock, Dieter Moosmayer, Christian M. Stegmann, Ursula Egner, Cheryl Arrowsmith, Dalia Barsyte-Loyejoy, Masoud Vedadi, Matthieu Schapira

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Small Molecule Antagonists of the Interaction between the Histone Deacetylase 6 Zinc-Finger Domain and Ubiquitin

Rachel J. Harding, Renato Ferreira de Freitas, Patrick Collins, Ivan Franzoni, Mani Ravichandran, Hui Ouyang, Kevin A. Juarez-Ornelas, Mark Lautens, Matthieu Schapira, Frank von Delft, Vjayaratnam Santhakumar, Cheryl H. Arrowsmith

JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Biochemistry & Molecular Biology

A systematic analysis of atomic protein-ligand interactions in the PDB

Renato Ferreira de Freitas, Matthieu Schapira

MEDCHEMCOMM (2017)

Article Chemistry, Medicinal

Identification and Structure-Activity Relationship of HDAC6 Zinc-Finger Ubiquitin Binding Domain Inhibitors

Renato Ferreira de Freitas, Rachel J. Harding, Ivan Franzoni, Mani Ravichandran, Mandeep K. Mann, Hui Ouyang, Mark Lautens, Vijayaratnam Santhakumar, Cheryl H. Arrowsmith, Matthieu Schapira

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Biochemistry & Molecular Biology

Identification and characterization of the first fragment hits for SETDB1 Tudor domain

Pavel Mader, Rodrigo Mendoza-Sanchez, Aman Iqbal, Aiping Dong, Elena Dobrovetsky, Victoria B. Corless, Sean K. Liew, Scott R. Houliston, Renato Ferreira De Freitas, David Smil, Carlo C. Dela Sena, Steven Kennedy, Diego B. Diaz, Hong Wu, Ludmila Dombrovski, Abdellah Allali-Hassani, Jinrong Min, Matthieu Schapira, Masoud Vedadi, Peter J. Brown, Vijayaratnam Santhakumar, Andrei K. Yudin, Cheryl H. Arrowsmith

BIOORGANIC & MEDICINAL CHEMISTRY (2019)

Article Chemistry, Medicinal

Selective, Small-Molecule Co-Factor Binding Site Inhibition of a Su(var)3-9, Enhancer of Zeste, Trithorax Domain Containing Lysine Methyltransferase

Alexandria P. Taylor, Magdalena Swewczyk, Steven Kennedy, Viacheslav V. Trush, Hong Wu, Hong Zeng, Aiping Dong, Renato Ferreira de Freitas, John Tatlock, Robert A. Kumpf, Martin Wythes, Agustin Casimiro-Garcia, Rajiah Aldrin Denny, Mihir D. Parikh, Fengling Li, Dalia Barsyte-Lovejoy, Matthieu Schapira, Masoud Vedadi, Peter J. Brown, Cheryl H. Arrowsmith, Dafydd R. Owen

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Chemistry, Medicinal

Discovery of Small Molecule Antagonists of the USP5 Zinc Finger Ubiquitin-Binding Domain

Mandeep K. Mann, Ivan Franzoni, Renato Ferreira de Freitas, Wolfram Tempel, Scott Houliston, Leanna Smith, Masoud Vedadi, Cheryl H. Arrowsmith, Rachel J. Harding, Matthieu Schapira

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Biochemistry & Molecular Biology

Methyltransferase Inhibitors: Competing with, or Exploiting the Bound Cofactor

Renato Ferreira de Freitas, Danton Ivanochko, Matthieu Schapira

MOLECULES (2019)

Article Chemistry, Medicinal

Discovery of Small-Molecule Antagonists of the PWWP Domain of NSD2

Renato Ferreira de Freitas, Yanli Liu, Magdalena M. Szewczyk, Naimee Mehta, Fengling Li, David McLeod, Carlos Zepeda-Velazquez, David Dilworth, Ronan P. Hanley, Elisa Gibson, Peter J. Brown, Rima Al-Awar, Lindsey James, Cheryl H. Arrowsmith, Dalia Barsyte-Lovejoy, Jinrong Min, Masoud Vedadi, Matthieu Schapira, Abdellah Allali-Hassani

Summary: This study identified the first antagonist that blocks the interaction between NSD2 and H3K36me2, providing a potential new approach for targeting NSD2 and further understanding its cellular function.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

A chemical probe targeting the PWWP domain alters NSD2 nucleolar localization

David Dilworth, Ronan P. Hanley, Renato Ferreira de Freitas, Abdellah Allali-Hassani, Mengqi Zhou, Naimee Mehta, Matthew R. Marunde, Suzanne Ackloo, Raquel Arminda Carvalho Machado, Aliakbar Khalili Yazdi, Dominic D. G. Owens, Victoria Vu, David Y. Nie, Mona Alqazzaz, Edyta Marcon, Fengling Li, Irene Chau, Albina Bolotokova, Su Qin, Ming Lei, Yanli Liu, Magdalena M. Szewczyk, Aiping Dong, Sina Kazemzadeh, Tigran Abramyan, Irina K. Popova, Nathan W. Hall, Matthew J. Meiners, Marcus A. Cheek, Elisa Gibson, Dmitri Kireev, Jack F. Greenblatt, Michael-C Keogh, Jinrong Min, Peter J. Brown, Masoud Vedadi, Cheryl H. Arrowsmith, Dalia Barsyte-Lovejoy, Lindsey James, Matthieu Schapira

Summary: NSD2 is an enzyme responsible for dimethylation of lysine 36 of histone 3, with multiple domains involved in chromatin reading. The chemical probe UNC6934 can modulate NSD2 activity and localization, affecting cellular functions.

NATURE CHEMICAL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Assessing the performance of docking, FEP, and MM/GBSA methods on a series of KLK6 inhibitors

Wemenes Jose Lima Silva, Renato Ferreira de Freitas

Summary: This study investigates the accuracy and efficiency of different computational methods and protocols to predict the free energy of binding for a series of KLK6 inhibitors. The results show that the performance of the methods varied strongly depending on the system. The free energy perturbation (FEP) method showed improved binding affinity predictions and ranked the most potent compounds at the top of the list in a simulation of a real-world drug discovery project.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2023)

Article Chemistry, Medicinal

Discovery and Characterization of a Chemical Probe Targeting the Zinc-Finger Ubiquitin-Binding Domain of HDAC6

Rachel J. Harding, Ivan Franzoni, Mandeep K. Mann, Magdalena M. Szewczyk, Bijan Mirabi, Renato Ferreira de Freitas, Dominic D. G. Owens, Suzanne Ackloo, Alexej Scheremetjew, Kevin A. Juarez-Ornelas, Randy Sanichar, Rachel J. Baker, Christian Dank, Peter J. Brown, Dalia Barsyte-Lovejoy, Vijayaratnam Santhakumar, Matthieu Schapira, Mark Lautens, Cheryl H. Arrowsmith

Summary: Inhibition of HDAC6-UBD is a promising strategy for treating cancers, and a potent chemical probe SGC-UBD253 (25) has been developed for targeting HDAC6-UBD. A methylated derivative SGC-UBD253N (32) was also identified as a negative control. These findings provide insights into the biological function of HDAC6-UBD and the therapeutic potential of targeting this domain.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

暂无数据